D-Index & Metrics Best Publications
Immunology
Greece
2022

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 64 Citations 14,083 147 World Ranking 1412 National Ranking 3
Medicine D-index 88 Citations 33,116 311 World Ranking 6545 National Ranking 12

Research.com Recognitions

Awards & Achievements

2022 - Research.com Immunology in Greece Leader Award

2018 - Member of Academia Europaea

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Gene

His primary areas of investigation include Immunology, Internal medicine, Lupus nephritis, Lupus erythematosus and MEDLINE. He has included themes like Gastroenterology and Endocrinology in his Internal medicine study. His biological study spans a wide range of topics, including Surgery, Kidney disease, Cyclophosphamide, Nephropathy and Systemic lupus erythematosus.

Dimitrios T. Boumpas focuses mostly in the field of Surgery, narrowing it down to matters related to Pharmacotherapy and, in some cases, Randomized controlled trial. His Lupus erythematosus study combines topics from a wide range of disciplines, such as Autoantibody, Antiphospholipid syndrome, Autoimmune disease and Anti-SSA/Ro autoantibodies. The MEDLINE study combines topics in areas such as Rheumatism, Delphi method and Physical therapy.

His most cited work include:

  • Treating rheumatoid arthritis to target: recommendations of an international task force (1479 citations)
  • Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis (671 citations)
  • Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis (649 citations)

What are the main themes of his work throughout his whole career to date?

Dimitrios T. Boumpas spends much of his time researching Internal medicine, Immunology, Systemic lupus erythematosus, Rheumatoid arthritis and Lupus nephritis. His work deals with themes such as Gastroenterology, Lupus erythematosus and Endocrinology, which intersect with Internal medicine. His Rheumatoid arthritis study combines topics in areas such as Surgery, Physical therapy, Infliximab and Arthritis.

In his research, Family medicine is intimately related to MEDLINE, which falls under the overarching field of Physical therapy. His Lupus nephritis research focuses on Cyclophosphamide and how it relates to Azathioprine and Rituximab. In his study, Clinical trial is inextricably linked to Intensive care medicine, which falls within the broad field of Disease.

He most often published in these fields:

  • Internal medicine (46.36%)
  • Immunology (44.81%)
  • Systemic lupus erythematosus (32.01%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (46.36%)
  • Systemic lupus erythematosus (32.01%)
  • Disease (22.30%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Internal medicine, Systemic lupus erythematosus, Disease, Cohort and Rheumatology. He works mostly in the field of Internal medicine, limiting it down to concerns involving Lupus erythematosus and, occasionally, Autoantibody. The various areas that he examines in his Systemic lupus erythematosus study include Dermatology, Lupus nephritis, Immunology and Dysbiosis.

His studies deal with areas such as Belimumab, Cyclophosphamide, Kidney disease and Rituximab as well as Lupus nephritis. His study explores the link between Immunology and topics such as Transcriptome that cross with problems in Progenitor cell. His study in Rheumatology is interdisciplinary in nature, drawing from both Multiple sclerosis, Adverse effect, MEDLINE and Family medicine.

Between 2018 and 2021, his most popular works were:

  • 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. (372 citations)
  • 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus (197 citations)
  • 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus (173 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Gene

His primary areas of study are Systemic lupus erythematosus, Internal medicine, Cohort, Rheumatism and Lupus nephritis. His Systemic lupus erythematosus research incorporates elements of Dermatology, Genetics and Epigenetic Process, DNA methylation. His Internal medicine study incorporates themes from Lupus erythematosus and Cardiology.

Dimitrios T. Boumpas combines subjects such as Calcineurin, Kidney disease and Rituximab with his study of Lupus nephritis. The study incorporates disciplines such as Autoimmunity and Immunology in addition to Genotype. Dimitrios T. Boumpas interconnects Autophagy and Stem cell in the investigation of issues within Immunology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Treating rheumatoid arthritis to target: recommendations of an international task force

Josef S. Smolen;Daniel Aletaha;Johannes W J W Bijlsma;Ferdinand C Breedveld.
Annals of the Rheumatic Diseases (2010)

2471 Citations

Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

George K Bertsias;Maria Tektonidou;Zahir Amoura;Martin Aringer.
Annals of the Rheumatic Diseases (2012)

1012 Citations

Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates

Dimitrios T. Boumpas;George P. Chrousos;Ronald L. Wilder;Thomas R. Cupps.
Annals of Internal Medicine (1993)

987 Citations

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

D.T. Boumpas;H.A. Austin;J.E. Balow;E.M. Vaughan.
The Lancet (1992)

941 Citations

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics

G. Bertsias;J. P. A. Ioannidis;J. Boletis;S. Bombardieri.
Annals of the Rheumatic Diseases (2008)

853 Citations

Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis : A randomized, controlled trial

Mark F. Gourley;Howard A. Austin;Dorothy Scott;Cheryl H. Yarboro.
Annals of Internal Medicine (1996)

717 Citations

EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

G K Bertsias;J P A Ioannidis;M Aringer;E Bollen.
Annals of the Rheumatic Diseases (2010)

678 Citations

A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis.

Dimitrios T. Boumpas;Richard Furie;Susan Manzi;Gabor G. Illei.
Arthritis & Rheumatism (2003)

619 Citations

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

Gabor G. Illei;Howard A. Austin;Marianna Crane;Lee Collins.
Annals of Internal Medicine (2001)

606 Citations

Risk for Sustained Amenorrhea in Patients with Systemic Lupus Erythematosus Receiving Intermittent Pulse Cyclophosphamide Therapy

Dimitrios T. Boumpas;Howard A. Austin;Ellen M. Vaughan;Cheryl H. Yarboro.
Annals of Internal Medicine (1993)

583 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Dimitrios T. Boumpas

Paul Emery

Paul Emery

University of Leeds

Publications: 114

Laure Gossec

Laure Gossec

Sorbonne University

Publications: 102

David A. Isenberg

David A. Isenberg

University College London

Publications: 90

Michelle Petri

Michelle Petri

Johns Hopkins University School of Medicine

Publications: 78

Josef S. Smolen

Josef S. Smolen

Medical University of Vienna

Publications: 77

Yoshiya Tanaka

Yoshiya Tanaka

University of Occupational and Environmental Health Japan

Publications: 77

Graciela S. Alarcón

Graciela S. Alarcón

University of Alabama at Birmingham

Publications: 74

Tsutomu Takeuchi

Tsutomu Takeuchi

Keio University

Publications: 70

Andrea Doria

Andrea Doria

University of Padua

Publications: 70

Maxime Dougados

Maxime Dougados

Hôpital Cochin

Publications: 66

Tore K. Kvien

Tore K. Kvien

University of Oslo

Publications: 63

Ricard Cervera

Ricard Cervera

University of Barcelona

Publications: 62

Désirée van der Heijde

Désirée van der Heijde

Leiden University Medical Center

Publications: 59

Dafna D. Gladman

Dafna D. Gladman

Toronto Western Hospital

Publications: 59

Yehuda Shoenfeld

Yehuda Shoenfeld

Sheba Medical Center

Publications: 57

Ronald F. van Vollenhoven

Ronald F. van Vollenhoven

University of Amsterdam

Publications: 57

Something went wrong. Please try again later.